Cargando…
Role of STAT3 and NRF2 in Tumors: Potential Targets for Antitumor Therapy
Signal transducer and activator of transcription 3 (STAT3) and nuclear factor erythroid-derived 2-like 2 (NRF2, also known as NFE2L2), are two of the most complicated transcription regulators, which participate in a variety of physiological processes. Numerous studies have shown that they are overac...
Autores principales: | Tian, Yanjun, Liu, Haiqing, Wang, Mengwei, Wang, Ruihao, Yi, Guandong, Zhang, Meng, Chen, Ruijiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781355/ https://www.ncbi.nlm.nih.gov/pubmed/36557902 http://dx.doi.org/10.3390/molecules27248768 |
Ejemplares similares
-
The Protective Effects and Mechanisms of Apelin/APJ System on Ischemic Stroke: A Promising Therapeutic Target
por: Tian, Yanjun, et al.
Publicado: (2020) -
Antitumor Therapy Targeting the Tumor Microenvironment
por: Gao, Yuewen, et al.
Publicado: (2023) -
Renieramycin T Inhibits Melanoma B16F10 Cell Metastasis and Invasion via Regulating Nrf2 and STAT3 Signaling Pathways
por: Yu, Baohua, et al.
Publicado: (2022) -
Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
por: Zhang, T, et al.
Publicado: (2017) -
The Role of Mesenchymal Stem Cells and Exosomes in Tumor Development and Targeted Antitumor Therapies
por: Yang, Enguang, et al.
Publicado: (2023)